CRISPR-based platform pinpoints drivers of leukemia in patient cells
February 26, 2026
February 26, 2026
PHILADELPHIA, Pennsylvania, Feb. 26 -- The University of Pennsylvania's Perelman School of Medicine posted the following news:
* * *
CRISPR-based platform pinpoints drivers of leukemia in patient cells
*
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone marrow and blood. This first-of-its . . .
* * *
CRISPR-based platform pinpoints drivers of leukemia in patient cells
*
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone marrow and blood. This first-of-its . . .